A clinical trial to test a new cancer drug in patients with advanced solid tumours has launched in four centres across the UK, through Cancer Research UK’s Centre for Drug Development.
This early phase trial will test the safety and tolerability of the drug and establish the recommended dose for patients with a variety of cancers including advanced bowel, lung, ovarian, urothelial, pancreatic, breast, head and neck, and oesophageal cancer.
Court orders Johnson & Johnson to compensate woman who claims her cancer was linked to using talc products for feminine hygiene
Pharmaceutical company Johnson & Johnson (J&J) has been ordered to pay $417m (£324m) to a terminally ill woman who claimed in a lawsuit that the talc in its iconic baby powder causes ovarian cancer when applied regularly for feminine hygiene.
The case was brought forward by Eva Echeverria from Los Angeles and is the largest sum awarded in a series of lawsuits alleging J&J failed to warn consumers adequately about the cancer risks of its talc-based products.
Second opinion from health experts available online for cancer patients from Trustedoctor
A new company is offering cancer patients a second opinion from experts around the world via virtual consultation.
The Trustedoctor platform aims to break down the “geographical barriers” in healthcare by letting patients securely upload their medical records, MRI scans and other documents to a website, and then discuss their case via video or messaging with a specialist in their specific condition.
Some of Britain’s top comedians will perform at this year’s Edinburgh Festival Fringe to help raise funds for a cancer charity.
Underbelly, one of the Fringe’s biggest venues, is partnering with The Brain Tumour Charity for an all-star evening of live comedy. The Big Brain Benefit Show will take place in Edinburgh at the Underbelly on August 23.
The rate of people dying from bowel cancer in the UK has dropped by more than 30% in the last 20 years, according to new figures released by Cancer Research UK.
Bowel cancer was responsible for 38 deaths per 100,000 people in 1995, falling to 26 deaths per 100,000 people by 2015. The drop in rates, taking into account changing population figures, equates to a decrease in bowel cancer deaths from 17,600 in 1995 to 15,800 in 2015.
Experts believe better treatment lies behind the dramatic drop in deaths. Improved public awareness among both patients and doctors, the bowel screening programme, may also be playing a part.
However, while the disease’s mortality rates continue to decline, bowel cancer is still the second most common cause of cancer death in the UK – accounting for 10% of all cancer deaths.
Money raised from the unique piece of jewellery will go to vital funds for cancer treatment in northeast Scotland
A group of women in Scotland will raffle off a unique piece of jewellery later this month to raise vital funds for cancer treatment.
The group, made up of local business women and friends from Aberdeen hope to raise money to help the breast care unit at Aberdeen Royal Infirmary treat those suffering from cancer. The fundraiser’s star attraction is a special piece of jewellery made by local jeweller Jay Sprigg.
Especially for the raffle, Sprigg has created a one-of-a-kind 18-karat white gold necklace which features 20 diamonds – one of which is a stunning pink diamond.
The hair brand wants to inspire people to donate their leftover locks from their next haircut so they can be transformed into wigs for kids and teenagers
Hair brand ghd has launched a new project this month to encourage people to donate their leftover locks from their next haircut.
The #choptoyourchin campaign is an initiative running throughout August, September and October to inspire you to make the big chop for a children’s charity.
Partnering with the Little Princess Trust, the charity will be accepting hair that is 7 inches or longer to be used to make wigs for children and young adults in the UK and Ireland who are having treatment for cancer and other illnesses.